Archive: program director

• Getting the Story Straight on Menopause: Program Co-Director Comments in New Opinion Piece

  From NPR to Oprah, "menopause awareness and support" bills are popping up in the news. Is this a step forward for women's health, or a step back into medical misinformation? In a new opinion piece

  Category: News Tags: advocacy, gender, Health Justice, program director, Publications, research

• Curious About the HAPI Program? New Info Session Dates Announced!

  Are you passionate about improving healthcare outcomes through advocacy in the heart of national and local efforts? Are you looking to join a community of dedicated public health leaders making syste

  Category: News Tags: admissions, info session, program director, public health

• Health System Performance Unveiled: HAPI Seminar Spotlit in The Hoya

  The Hoya, Georgetown's student newspaper, highlighted our first seminar of the fall semester, "Health System Performance Unveiled" with HAPI faculty member Dr. Vincent Turbat. Dr. Adam Myers, the

  Category: News Tags: program director, Publications, seminar, student spotlight

• Menopausal Hormone Therapy: Limited Benefits, Significant Harms

  Program Co-Director Adriane Fugh-Berman and colleague Dr. Mintzes recently published an editorial in the American Family Physician Journal highlighting the shaky evidence for menopausal hormone thera

  Category: News Tags: health and gender, Health Justice, program director, Publications, research

• RFK Jr.’s Immunity to Scientific Evidence is Dangerous: Co-Director Comments

  As a physician with a long career in alternative medicine and who opposes pharmaceutical marketing, you might think I have a lot in common with Robert F Kennedy Jr. You’d be wrong. Dr. Adriane Fugh-

  Category: News Tags: advocacy, Health Justice, program director, Publications

• A Hard Look at Prescribing: Program Co-Director Comments on New Opioid Study

  This February, Program Co-Director Adriane Fugh-Berman and her colleague, Judy Butler, authored an article breaking down a new study on opioid prescribing and use disorders. According to the research

  Category: News Tags: drug marketing, pharmedout, program director, Publications, research

• History Repeating? Program Co-Director Comments on “Non-Addictive” Pain Pill in The Washington Post

  This week, Dr. Adriane Fugh-Berman, Co-Director of the M.S. HAPI program, commented on a new pain pill set for FDA review this January. The drug is non-opioid and aims to be an alternative to pre

  Categories: Announcements, News Tags: drug marketing, program director, Publications, research

• Advocacy in Action: PharmedOut Organizes a Letter Challenging “Dangerous Disinformation”

  A recent STAT news article covers Program Co-Director Dr. Adriane Fugh-Berman's organization, PharmedOut, which has organized a letter signed by multiple experts on women's health "demanding that the

  Category: News Tags: drug marketing, pharmedout, program director, Publications

• “A New Dystopic Era”: Dr. Fugh-Berman on Pharmaceutical Companies Selling Direct

  Dr. Fugh-Berman and her colleague at PharmedOut, Judy Butler, have just published an opinion piece in STAT news on an alarming new pharmaceutical practice: selling prescription drugs directly to cons

  Category: News Tags: drug marketing, pharmedout, program director, Publications

• Peer Reviewers Made $1 Billion in 3 Years: Dr. Fugh-Berman Featured in MedPage Today on Medical Journal Financial Conflicts

  More than half of peer reviewers for four top medical journals received payments from drug and medical device manufacturers, totaling $1.06 billion, from 2020 to 2022, according to an analysis of th

  Categories: Advocacy, News Tags: drug marketing, pharmedout, program director, Publications